[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: EDE from FDG
- To: radsafe@romulus.ehs.uiuc.edu
- Subject: Re: EDE from FDG
- From: Karin Gordon <kgordon@cc.UManitoba.CA>
- Date: Wed, 13 May 1998 12:06:44 -0500
- Organization: Radiation Safety, Health Sciences Centre, Winnipeg
- References: <199805131439.JAA28244@romulus.ehs.uiuc.edu>
Look at the 1987 ICRP Publication 53 "Radiation Dose to Patients from
Radiopharmaceuticals" for detailed organ and tissue doses (mGy/MBq),
which are still accurate. Ignore the effective dose quoted in ICRP 53
because it was published using the old tissue weighting factors prior to
ICRP-60. ICRP-62 contains an addendum to Publication 53, updating the
effective dose (mSv/MBq) for radiopharmaceuticals, taking the new tissue
wieghting factors into account.ICRP-62 states the effective dose from
Tc-99m phosphates and phosphonates (used for bone imaging) to be 5.8E-03
mSv/MBq. The standard amount of activity given for a bone scan is 740
MBq (20 mCi), so your effective dose from the procedure is 4.29 mSv (429
mrem).
By the way, the old ICRP-53 effective dose was higher (8.0E-03 mSv/MBq),
which calculated out to 5.92 mSv, giving a difference of 1.63 mSv,
depending when you underwent the procedure!! Ain't science grand ;-)
Karin Gordon
Radiation Safety Officer
Health Sciences Centre
Winnipeg, Manitoba
KGordon@cc.UManitoba.ca